Effects of inhibitors of Toll-like receptors, protease-activated receptor-2 signalings and trypsin on influenza A virus replication and upregulation of cellular factors in cardiomyocytes

Journal of Medical Investigation

Volumn 58, Issue 1-2, 2011, Pages 19-28

  Pan, Hai Yan ^a   Yano, Mihiro ^a   Kido, Hiroshi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Cardiomyocyte; Influenza A virus; Proteinase activated receptor 2; Toll like receptor

Indexed keywords

BETA INTERFERON; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; PROTEINASE ACTIVATED RECEPTOR 2; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRYPSIN; TRYPSINOGEN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEART MUSCLE CELL; INFLUENZA VIRUS A; NONHUMAN; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS REPLICATION;

INFLUENZA A VIRUS; MUS;

EID: 79951901504     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.58.19     Document Type: Article

References (44)

1. Mamas MA, Fraser D, Neyses L: Cardiovascular manifestations associated with influenza virus infection. Int J Cardiol 130: 304-309, 2008
2. Warren-Gash C, Smeeth L, Hayward AC: Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systemic review. Lancet Infect Dis 10: 601-610, 2009
3. Klenk HD, Rott R, Orlich M, Blödom J: Activation of influenza A viruses by trypsin treatment. Virology 68: 426-439, 1975
4. Kido H, Okumura Y, Yamada H, Le TQ, Yano M: Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents. Curr Pharm Des 13: 405-414, 2007
5. Le TQ, Kawachi M, Yamada H, Shiota M, Okumura Y, Kido H: Identification of trypsin I as a candidate for influenza A virus and Sendai virus envelope glycoprotein processing protease in rat brain. Biol Chem 387: 467-475, 2006
6. Wang S, Le TQ, Kurihara N, Chida J, Cisse Y., Yano M, Kido H: Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza. J Infect Dis 202(7): 991-1001, 2010
7. Akira S, Yamamoto M, Takeda K: Role of adapters in Toll-like receptor signalling. Bio-chem Soc Trans 31: 637-642, 2003
8. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol. 21: 335-376, 2003
9. Barton GM: Viral recognition by Toll-like receptors. Semin Immunol 19: 33-40, 2007
10. Tabeta K, Georgel P, Janssen E, Du X, Hoebe K, Crozat K, Mudd S, Shamel L, Sovath S, Goode J, Alexopoulou L, Flavell RA, Beutler B: Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci USA 101: 3516-21, 2004
11. Samuel CE: Antiviral actions of interferons. Clin Microbiol Rev: 14: 778-809, 2001
12. Mogensen TH, Paludan SR: Molecular pathways in virus-induced cytokine production. Mi-crobiol Mol Biol Rev 65: 131-50, 2001
13. Pauligk C, Nain M, Reiling N, Gemsa D, Kaufmann A: CD14 is required for influenza A virus-induced cytokine and chemokine production. Immunobiology 209: 3-10, 2004
14. Wang JP, Bowen GN, Padden C, Cerny A, Finberg RW, Newburger PE, Kurt-Jones EA: Toll-like receptor-mediated activation of neu-trophils by influenza A virus. Blood 112: 2028-2034, 2008
15. Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, Flavell R, Chignard M, Si-Tahar M: Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog 2: e53, 2006
16. Steinhoff M, Buddenkotte J, Shpacovitch V, Rattenholl A, Moormann C, Vergnolle N, Luger TA, Hollenberg MD: Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 26: 1-43, 2005
17. Niu QX, Chen HQ, Chen ZY, Fu YL, Lin JL, He SH: Induction of inflammatory cytokine release from human umbilical vein endothelial cells by agonists of proteinase - activated receptor - 2. Clin Exp Pharmacol Physiol 35: 89-96, 2008
18. Vliagoftis H, Schwingshackl A, Milne CD, Duszyk M, Hollenberg MD, Wallace JL, Befus AD, Moqbel R: Proteinase-activated receptor-2-mediated matrix metalloproteinase-9 release from airway epithelial cells. J Allergy Clin Immunol 106: 537-545, 2000
19. Shpacovitch VM, Varga G, Strey A, Gunzer M, Mooren F, Buddenkotte J, Vergnolle N, Sommerhoff CP, Grabbe S, Gerke V, Homey B, Hollenberg M, Luger TA, Steinhoff M: Agonists of proteinase-activated receptor-2 modulate human neutrophil cytokine secretion, expression of cell adhesion molecules, and migration within 3-D collagen lattices. J Leukoc Biol 76: 388-398, 2004
20. Vempati P, Karagiannis ED, Popel AS: A biochemical model of matrix metalloproteinase 9 activation and inhibition. J Biol Chem 282: 37585-37596, 2007
21. Rosário HS, Waldo SW, Becker S, Schmid-Schönbein GW: Pancreatic trypsin increases matrix metalloproteinase-9 accumulation and activation during acute intestinal ischemia-reper-fusion in the rat. Am J Pathol 164: 1707-1716, 2004
22. Marchant D, McManus BM: Matrix metallo-proteinases in the pathogenesis of viral heart disease. Trends Cardiovasc Med 19: 21-26, 2009
23. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL, Leber TM, Mangan M, Miller K, Nayee P, Owen K, Patel S, Thomas W, Wells G, Wood LM, Woolley K: Processing of tumor necrosis factor-α precursor by metalloprotein-ases. Nature 370: 555-557, 1994
24. Hozumi A, Nishimura Y, Nishiuma T, Kotani Y, Yokoyama M. Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappa B-mediated pathway. Am J Physiol Lung Cell Mol Physiol 281: L1444-L1452, 2001
25. Siwik DA, Chang DL, Colucci WS: Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metal-loproteinase activity in cardiac fibroblasts in vitro. Circ Res 86: 1259-1265, 2000
26. Flory E, Kunz M, Scheller C, Jassoy C, Stauber R, Rapp UR, Ludwig S: Influenza virus-induced NF-kappaB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IkappaB kinase. J Biol Chem 275: 8307-14, 2000
27. Nimmerjahn F, Dudziak D, Dirmeier U, Hobom G, Riedel A, Schlee M, Staudt LM, Rosenwald A, Behrends U, Bornkamm GW, Mautner J: Active NF-kappaB signalling is a prerequisite for influenza virus infection. J Gen Virol 85: 2347-2356, 2004
28. Kumar N, Xin ZT, Liang Y, Ly H, Liang Y: NF-kappaB signaling differentially regulates influenza virus RNA synthesis. J Virol 82: 9880-9889, 2008
29. Knobil K, Choi AM, Weigand GW, Jacoby DB: Role of oxidants in influenza virus - induced gene expression. Am J Physiol 274: L134-L142, 1998
30. Goffic RL, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, Flavell R, Chignard M, Si - Tahar M: Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLos 2: 0526-0535, 2006
31. Reemers SS, van Haarlem DA, Koerkamp MJG, Vervelde L: Differential gene-expression and host-response profiles against avian influenza virus within the chicken lung due to anatomy and airflow. J Gen Viriol 90: 2134-2146, 2009
32. Sanghavi SK, Reinhart TA: Increased expression of TLR3 in lymph nodes during simian immunodeficiency virus infection: implications for inflammation and immunodeficiency. J Immunol 175: 5314-23, 2005
33. Bekeredjian-Ding IB, Wagner M, Hornung V, Giese T, Schnurr M, Endres S, Hartmann G: Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J Immunol 174: 4043-50, 2005
34. Schreck R, Meier B, Männel DN, Dröge W, Baeuerle PA: Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 175: 1181-1194, 1992
35. Brennan P, O'Neill LA: 2-mercaptoethanol restores the ability of nuclear factor kappa B (NF kappa B) to bind DNA in nuclear extracts from interleukin 1-treated cells incubated with py-rollidine dithiocarbamate (PDTC). Evidence for oxidation of glutathione in the mechanism of inhibition of NF kappa B by PDTC. Biochem J 320: 975-981, 1996
36. Klenk HD, Rott R: The molecular biology of influenza virus pathogenicity. Adv Virus Res 34: 247-281, 1988
37. Kido H, Okumura Y, Takahashi E, Pan H, Wang S, Chida J, Le TQ, Yano M: Host envelope glycoprotein processing proteases are indispensable for entry into human cells by seasonal and highly pathogenic avian influenza viruses. J Mol Gen Med 3: 167-175, 2009
38. Paszcuk AF, Quintão NL, Fernandes ES, Juliano L, Chapman K, Andrade-Gordon P, Campos MM, Vergnolle N, Calixto JB: Mechanisms underlying the nociceptive and inflammatory responses induced by trypsin in the mouse paw. Eur J Pharmacol 581: 204-215, 2008
39. Shpacovitch VM, Brzoska T, Buddenkotte J, Stroh C, Sommerhoff CP, Ansel JC, Schulze-Osthoff K, Bunnett NW, Luger TA, Steinhoff M: Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells. J Invest Dermatol 118: 380-385, 2002
40. Macfarlane SR, Plevin R: Intracellular Signalling by the G -Protein Coupled Proteinase -Activated Receptor (PAR) Family. Drug Dev Res 59: 367-374, 2003
41. Lohman RJ, O'Brien TJ, Cocks TM: Protease-activated receptor-2 regulates trypsin expression in the brain and protects against seizures and epileptogenesis. Neurobiol Dis 30: 84-93, 2008
42. DeFea KA, Zalevsky J, Thoma MS, Déry O, Mullins RD, Bunnett NW: β-Arrestin-depend-ent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148: 1267-1281, 2000
43. Sharma A, Tao X, Gopal A, Ligon B, Andrade-Gordon P, Steer ML, Perides G: Protection against acute pancreatitis by activation of pro-tease-activated receptor-2. Am J Physiol Gas-trointest Liver Physiol 288: G388-G395, 2005
44. Al-Ani B, Saifeddine M, Wijesuriya SJ, Hollenberg MD: Modified proteinase -activated receptor-1 and -2 derived peptides inhibit pro-teinase-activated receptor-2 activation by tryp-sin. J Pharmacol Exp Ther 300: 702-708, 2002